Showing results (1311-1320 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|July 29, 2017
Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemiaC Skrabs, W F Pickl, T Perkmann, et al.Journal of Clinical Pharmacy and Therapeutics|July 7, 2016
Double benefit of long-acting somatostatin analogs in a patient with coexistence of acromegaly and ulcerative colitisS Yarman, G Y Yalın, S C Dogansen, et al.Journal of Clinical Pharmacy and Therapeutics|July 7, 2016
Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot studyS Samuel, T A Allison, S Sharaf, et al.Journal of Clinical Pharmacy and Therapeutics|July 9, 2016
Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature reviewA Rashidi, M A BlinderJournal of Clinical Pharmacy and Therapeutics|September 14, 2017
Enzalutamide-warfarin interaction necessitating warfarin dosage adjustment: A case report of successful clinical managementJ L Parrett, A B Reaves, T H Self, et al.Journal of Clinical Pharmacy and Therapeutics|September 13, 2017
Therapeutic drug monitoring of antitubercular agents for disseminated Mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltrationJ H Sin, R H Elshaboury, R M Hurtado, et al.Journal of Clinical Pharmacy and Therapeutics|September 13, 2017
We have had a gutful: The need for deprescribing proton pump inhibitorsM Naunton, G M Peterson, L S Deeks, et al.Journal of Clinical Pharmacy and Therapeutics|March 4, 2018
Genotype and allele frequencies of TYMS rs2790 A > G polymorphism in a Chinese paediatric population with acute lymphoblastic leukaemiaS-M Wang, W-X Zeng, W-S Wu, et al.Journal of Clinical Pharmacy and Therapeutics|November 9, 2017
Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after allW K ChinJournal of Clinical Pharmacy and Therapeutics|November 9, 2017
Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open-label, long-term safety and efficacy studyW Xu, C Xiang, H Wang, et al.Pageof 325